Wenqian Yang

2.1k total citations · 1 hit paper
62 papers, 1.5k citations indexed

About

Wenqian Yang is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Wenqian Yang has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 10 papers in Biomaterials and 10 papers in Biomedical Engineering. Recurrent topics in Wenqian Yang's work include Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (9 papers) and RNA modifications and cancer (8 papers). Wenqian Yang is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (9 papers) and RNA modifications and cancer (8 papers). Wenqian Yang collaborates with scholars based in China, Japan and United States. Wenqian Yang's co-authors include Horacio Cabral, Yongjun Wang, Zhonggui He, Haotian Zhang, Qiming Kan, Menglin Wang, Jin Sun, Yan Shen, Jing Gong and Jiasheng Tu and has published in prestigious journals such as Nucleic Acids Research, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Wenqian Yang

60 papers receiving 1.5k citations

Hit Papers

Polymer‐Based mRNA Delive... 2023 2026 2024 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenqian Yang China 20 801 448 383 187 170 62 1.5k
Xi Zhu China 17 857 1.1× 597 1.3× 492 1.3× 234 1.3× 172 1.0× 36 1.7k
Andrei Maksimenko France 25 1.1k 1.4× 394 0.9× 608 1.6× 143 0.8× 167 1.0× 38 1.9k
Sanyogitta Puri United Kingdom 14 734 0.9× 639 1.4× 726 1.9× 186 1.0× 82 0.5× 20 1.6k
Ting Jiang China 20 599 0.7× 521 1.2× 393 1.0× 194 1.0× 114 0.7× 46 1.4k
Aeju Lee South Korea 23 681 0.9× 569 1.3× 401 1.0× 195 1.0× 179 1.1× 38 1.4k
Chun Liu China 21 551 0.7× 377 0.8× 385 1.0× 165 0.9× 202 1.2× 54 1.4k
Yujie Shi China 23 799 1.0× 347 0.8× 226 0.6× 188 1.0× 169 1.0× 66 1.7k
Davide Demurtas Switzerland 26 1.0k 1.3× 403 0.9× 378 1.0× 339 1.8× 144 0.8× 36 1.9k
Imran Vhora India 21 877 1.1× 386 0.9× 617 1.6× 136 0.7× 108 0.6× 25 1.8k
Dipesh Baradia India 13 650 0.8× 290 0.6× 437 1.1× 107 0.6× 93 0.5× 16 1.4k

Countries citing papers authored by Wenqian Yang

Since Specialization
Citations

This map shows the geographic impact of Wenqian Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqian Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqian Yang more than expected).

Fields of papers citing papers by Wenqian Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenqian Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqian Yang. The network helps show where Wenqian Yang may publish in the future.

Co-authorship network of co-authors of Wenqian Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenqian Yang. A scholar is included among the top collaborators of Wenqian Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenqian Yang. Wenqian Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chiqi, et al.. (2025). The progression of multiple myeloma is regulated by LILRB1 via the GATA2SAGE1 pathway. British Journal of Haematology. 207(1). 69–79. 1 indexed citations
2.
Yang, Wenqian, et al.. (2025). Colorful patterns prepared using alicyclic epoxy-based cholesteric liquid crystal inks for decoration. Liquid Crystals. 52(5-6). 434–444. 1 indexed citations
3.
Wei, Xixi, Yang Wang, Weiling Zhao, et al.. (2025). Knockdown of ACC1 promotes migration and invasion of U251 glioma cells by epigenetically suppressing SDH. International Journal of Oncology. 67(3). 1–13. 1 indexed citations
4.
Xie, Li, Chiqi Chen, Wenqian Yang, et al.. (2024). LILRB4 regulates multiple myeloma development through STAT3-PFKFB1 pathway. Cell Death and Disease. 15(7). 515–515. 9 indexed citations
5.
Chen, Yanmin, et al.. (2024). Amlodipine inhibits the proliferation and migration of esophageal carcinoma cells through the induction of endoplasmic reticulum stress. World Journal of Gastroenterology. 30(4). 367–380. 6 indexed citations
6.
Wu, Hao, Wenqian Yang, Zixu Zhang, et al.. (2024). Deciphering the distinct roles of polyketide synthase subunits in polyunsaturated fatty acid and lipid accumulation in Schizochytrium sp.. Food Bioscience. 63. 105751–105751. 6 indexed citations
7.
Chen, Pengwen, Wenqian Yang, Koji Nagaoka, et al.. (2023). An IL‐12‐Based Nanocytokine Safely Potentiates Anticancer Immunity through Spatiotemporal Control of Inflammation to Eradicate Advanced Cold Tumors. Advanced Science. 10(10). e2205139–e2205139. 27 indexed citations
8.
Yang, Wenqian, et al.. (2023). Polymer‐Based mRNA Delivery Strategies for Advanced Therapies. Advanced Healthcare Materials. 12(15). e2202688–e2202688. 124 indexed citations breakdown →
9.
Yang, Zirun, et al.. (2023). Novel fast preparation of MoAlB phase cermet with elevated temperature oxidation resistance. Vacuum. 219. 112770–112770. 1 indexed citations
10.
Guo, Wenqi, et al.. (2023). Full-scale test and numerical modeling on deformation and damage behavior of segmental joints under ultimate compression-bending load. Engineering Structures. 279. 115648–115648. 29 indexed citations
11.
Ling, Yun, Gehao Liang, Qun Lin, et al.. (2022). circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer. Molecular Cancer. 21(1). 8–8. 67 indexed citations
12.
Chen, Pengwen, Wenqian Yang, Taehun Hong, et al.. (2022). Nanocarriers escaping from hyperacidified endo/lysosomes in cancer cells allow tumor-targeted intracellular delivery of antibodies to therapeutically inhibit c-MYC. Biomaterials. 288. 121748–121748. 34 indexed citations
13.
Yang, Wenqian, et al.. (2022). Polymeric Micelles with pH-Responsive Cross-Linked Core Enhance In Vivo mRNA Delivery. Pharmaceutics. 14(6). 1205–1205. 28 indexed citations
14.
Yang, Wenqian, Yuan Jiang, Qulian Guo, Zhixin Tian, & Zhigang Cheng. (2022). Aberrant N-glycolylneuraminic acid in breast MCF-7 cancer cells and cancer stem cells. Frontiers in Molecular Biosciences. 9. 1047672–1047672. 1 indexed citations
16.
Gao, Yingjie, Wenqian Yang, Weiwei Jin, et al.. (2022). Animal-SNPAtlas: a comprehensive SNP database for multiple animals. Nucleic Acids Research. 51(D1). D816–D826. 12 indexed citations
17.
Wang, Ru, Wenqian Yang, Yanyan Liu, et al.. (2021). A DM1-doped porous gold nanoshell system for NIR accelerated redox-responsive release and triple modal imaging guided photothermal synergistic chemotherapy. Journal of Nanobiotechnology. 19(1). 119–119. 30 indexed citations
18.
Yang, Wenqian, Takuya Miyazaki, Pengwen Chen, et al.. (2021). Block catiomer with flexible cationic segment enhances complexation with siRNA and the delivery performance in vitro. Science and Technology of Advanced Materials. 22(1). 850–863. 7 indexed citations
19.
Jin, Weiwei, Yanbo Yang, Wenqian Yang, et al.. (2021). Animal-eRNAdb: a comprehensive animal enhancer RNA database. Nucleic Acids Research. 50(D1). D46–D53. 17 indexed citations
20.
Safina, Brian S., Richard L. Elliott, Andrew K. Forrest, et al.. (2017). Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral Angles. ACS Medicinal Chemistry Letters. 8(9). 936–940. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026